Lee Scott Golden serves as Executive at PTC THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Lee Scott Golden has executed 9 insider transactions totaling $297.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 8, 2026 involved selling 866 shares valued at $66.2K.
Lee Scott Golden currently holds 92,428 shares of PTC THERAPEUTICS, INC. (PTCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lee Scott Golden has been a net seller of PTCT stock. They have purchased $0 and sold $297.5K worth of shares.
Lee Scott Golden's most recent insider trade was on Jan 8, 2026, when they sold 866 shares at $76.45 per share.
Get notified when new Form 4 filings are submitted
| $77.48 |
| Discretionary |
| Jan 6, 2026 | PTCT | $103.1K | Sale | 1,340 | $76.95 | Discretionary |
| May 7, 2024 | PTCT | $5.7K | Sale | 175 | $32.82 | Planned |
| Apr 2, 2024 | PTCT | $14.9K | Sale | 526 | $28.37 | Discretionary |
| Feb 15, 2024 | PTCT | $0 | Award | 2,600 | $N/A | Discretionary |
| Feb 15, 2024 | PTCT | $0 | Award | 20,000 | $N/A | Discretionary |
| Jan 9, 2024 | PTCT | $35.5K | Sale | 1,225 | $29.01 | Planned |
| Jan 8, 2024 | PTCT | $22.2K | Sale | 775 | $28.64 | Planned |